Direct-acting antivirals
59 articles
Minimum Costs to Produce Hepatitis C Direct-Acting Antivirals
by Andrew Hill, Bryony Simmons, Nikolien van de Van, Nathan Ford, Saye Khoo and Joe Fortunak
Minimum costs of treatment and diagnostics to cure hepatitis C were estimated at US$177-354 per person without genotyping, and US$267-444 per person with genotyping. More
Hepatitis C: No More Treatment Rationing; Universal Access to Generic Medicines Everywhere!
16 April 2016
People with HCV and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. More
HCV Basics and Treatments
A series of fact sheets, developed by Treatment Action Group, provides essential information on the most commonly prescribed DAAs to treat and effectively cure HCV. More
Epclusa Fact Sheet
A fact sheet, developed by Treatment Action Group, provides information about Epclusa - a fixed-dose combination of two HCV drugs (sofosbuvir and velpatasvir) in one pill. More
Have a Heart, Save My Liver! Where is the Cure Registered?
A fact sheet, developed by the hepCoalition, provides in-country data to understand where the branded and generic versions of the HCV cure have been registered and to inform advocacy efforts. More
